Harm Shield
Rapid field-testing kits against fentanyl exposure.
Function
Rapid field testing
Target threat
Fentanyl exposure
About
Role in the broader portfolio and the thesis it supports.
Harm Shield produces rapid, accurate field-testing kits to protect vulnerable populations from fentanyl exposure. The work is framed against the national fentanyl crisis — the DEA reported in 2023 that 7 of every 10 seized counterfeit pills carried lethal doses of fentanyl. A public-health adjacency to the broader life-sciences platform; Jeff Muoio carries portfolio responsibility.
More in Life Sciences
Adjacent work in the sector.
ActiveMarquis Labs
Full-service clinical laboratory anchoring the diagnostics layer.
~1%
Sample rejection rate
3×
Faster than baseline
~24hr
Result turnaround
ActiveCellestiq
Sister molecular-lab brand co-located with Marquis.
Oklahoma City
Lab base
Ledesma lab ecosystem
Affiliation
ActiveRio Grande Valley Labs
High-complexity CLIA lab in South Texas.
CLIA, high-complexity
Certification
1M+
Results to date
Alamo, TX
Base